Gastroenterology

Immune-related adverse events

Questions discussed in this category

In a patient with unresectable HCC who developed immune-related colitis with the first dose of tremelimumab/durvalumab, would you consider continuing durvalumab alone after resolution of the colitis with steroid treatment?

Would you consider a colonoscopy?

1 Answer available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Apr 11

Accelerating the Evolution of Immune-Related Enterocolitis Management.

Oncogene, 2023 Sep 21

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.

Related Topics in Gastroenterology